Amchit, Lebanon

Nader Al Nakouzi

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Institut Gustave Roussy. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nader Al Nakouzi. Retrieved from https://idiyas.com/inventor/nader-al-nakouzi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nader Al Nakouzi: Innovator in Prostate Cancer Research

Introduction

Nader Al Nakouzi is a prominent inventor based in Amchit, Lebanon. He has made significant contributions to the field of cancer research, particularly in the area of prostate cancer. His innovative work has the potential to impact the way prostate cancer is diagnosed and treated.

Latest Patents

Nader Al Nakouzi holds a patent for "Prostate cancer cell lines and their use in screening method." This invention relates to a prostate cancer cell line with CNCM deposit number I-4126. The patent outlines the use of this cell line for preparing resistant prostate cancer cell lines, as well as the application of these cell lines for screening compounds of interest. He has 1 patent to his name.

Career Highlights

Nader is currently affiliated with the Institut Gustave Roussy, a leading cancer research institution. His work at this prestigious organization allows him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Throughout his career, Nader has worked alongside notable colleagues such as Karim Fizazi and Jean Benard. These collaborations have further enriched his research and expanded the impact of his inventions.

Conclusion

Nader Al Nakouzi is a dedicated inventor whose work in prostate cancer research exemplifies innovation in the medical field. His contributions are paving the way for advancements in cancer treatment and screening methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…